DISCOUNT-ZERTIFIKAT - PFIZER INC Stock

Certificat

DE000KJ0RC44

Delayed Deutsche Boerse AG 01:26:19 2024-06-26 pm EDT
23.32 EUR -1.69% Intraday chart for DISCOUNT-ZERTIFIKAT - PFIZER INC
Current month+2.20%
1 month+1.72%
Date Price Change
24-06-26 23.32 -1.69%
24-06-25 23.72 +0.17%
24-06-24 23.68 +0.51%
24-06-21 23.56 -0.04%
24-06-20 23.57 +1.29%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 01:26 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Citi Citi
WKN KJ0RC4
ISINDE000KJ0RC44
Date issued 2023-10-19
Maturity 2024-12-19 (176 Days)
Parity 1 : 1
Emission price 23.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 23.85
Lowest since issue 20.68

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.99 USD
Average target price
31.92 USD
Spread / Average Target
+14.02%
Consensus